ALX Oncology Holdings Inc (ALXO)
15.36
-1.26
(-7.58%)
USD |
NASDAQ |
May 03, 16:00
15.36
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Market Cap: 770.34M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 770.34M |
| May 02, 2024 | 833.53M |
| May 01, 2024 | 849.58M |
| April 30, 2024 | 853.59M |
| April 29, 2024 | 849.08M |
| April 26, 2024 | 845.56M |
| April 25, 2024 | 846.07M |
| April 24, 2024 | 813.47M |
| April 23, 2024 | 777.36M |
| April 22, 2024 | 713.66M |
| April 19, 2024 | 782.37M |
| April 18, 2024 | 789.39M |
| April 17, 2024 | 806.45M |
| April 16, 2024 | 726.70M |
| April 15, 2024 | 646.46M |
| April 12, 2024 | 653.48M |
| April 11, 2024 | 671.04M |
| April 10, 2024 | 604.33M |
| April 09, 2024 | 618.88M |
| April 08, 2024 | 608.85M |
| April 05, 2024 | 613.36M |
| April 04, 2024 | 563.71M |
| April 03, 2024 | 541.64M |
| April 02, 2024 | 537.63M |
| April 01, 2024 | 552.68M |
| Date | Value |
|---|---|
| March 28, 2024 | 559.20M |
| March 27, 2024 | 572.24M |
| March 26, 2024 | 561.20M |
| March 25, 2024 | 587.78M |
| March 22, 2024 | 588.79M |
| March 21, 2024 | 627.40M |
| March 20, 2024 | 601.83M |
| March 19, 2024 | 579.76M |
| March 18, 2024 | 549.17M |
| March 15, 2024 | 566.72M |
| March 14, 2024 | 559.20M |
| March 13, 2024 | 581.76M |
| March 12, 2024 | 620.38M |
| March 11, 2024 | 675.05M |
| March 08, 2024 | 762.81M |
| March 07, 2024 | 814.47M |
| March 06, 2024 | 740.75M |
| March 05, 2024 | 740.75M |
| March 04, 2024 | 737.24M |
| March 01, 2024 | 753.79M |
| February 29, 2024 | 735.73M |
| February 28, 2024 | 724.80M |
| February 27, 2024 | 819.71M |
| February 26, 2024 | 821.71M |
| February 23, 2024 | 791.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
172.43M
Minimum
Aug 28 2023
4.166B
Maximum
Dec 10 2020
1.168B
Average
674.76M
Median
Market Cap Benchmarks
| Bristol-Myers Squibb Co | 89.17B |
| Nurix Therapeutics Inc | 780.44M |
| Exelixis Inc | 6.379B |
| Geron Corp | 2.331B |
| Verastem Inc | 275.85M |
Market Cap Related Metrics
| PS Ratio | 180.85 |
| Price to Book Value | 4.061 |
| Price | 15.36 |
| Earnings Yield | -24.35% |